Niagen Bioscience (NAGE) EPS (Basic) (2011 - 2026)
Niagen Bioscience (NAGE) posted quarterly EPS (Basic) of $0.08 for Q1 2026, up 21.5% year-over-year from $0.07 in Q1 2025, and up 51.49% quarter-over-quarter from $0.05 in Q4 2025.
Analysis
Niagen Bioscience (NAGE) EPS (Basic) (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported EPS (Basic) for 15 consecutive years, with $0.08 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 21.5% year-over-year to $0.08; the TTM figure through Mar 2026 stood at $0.23 (up 28.65% YoY), while the FY2025 annual figure was $0.22, up 94.96% from the prior year.
- EPS (Basic) climbed to $0.08 in Q1 2026 per NAGE's latest filing, from $0.05 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.09 in Q4 2024 and bottomed at -$0.17 in Q2 2022.
- Historically, EPS (Basic) has averaged -$0.02 across 5 years, with a median of -$0.0 in 2023.
- On a YoY basis, EPS (Basic) climbed as much as 23039.72% in 2025 and fell as far as 44.81% in 2025.
- Niagen Bioscience's EPS (Basic) stood at -$0.02 in 2022, then surged by 84.1% to -$0.0 in 2023, then soared by 2725.83% to $0.09 in 2024, then plunged by 44.81% to $0.05 in 2025, then surged by 51.49% to $0.08 in 2026.
- Business Quant data shows NAGE's EPS (Basic) at $0.08 in Q1 2026, $0.05 in Q4 2025, and $0.06 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.08 |
| Dec 31, 2025 | 0.05 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.09 |
| Mar 31, 2022 | -0.11 |
| Dec 31, 2021 | -0.08 |
| Sep 30, 2021 | -0.13 |